Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venugopal Gudipati

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Science Immunology|March 5, 2021
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responsesBenedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Science Immunology|March 5, 2021
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responsesBenedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, et al.
Pageof 3